Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

No-Receipt date 2023-00922 - 23/03/2023
No-Filing date 20230400471 - 23/03/2023
No-Granting date 3112232 - 31/03/2023
No-EPO application date 19213030.0 - 29/04/2013
No-EPO granting date 3677591 - 28/12/2022
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2023 - 10/04/2023
Expiration date 30/04/2033
Kind of title Validation of European Patent
Legal status VALID
Priorities -
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 38/21
A61P 35/00
A61P 35/02
C07K 14/56
C07K 16/28

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1483426 TEVA PHARMACEUTICALS AUSTRALIA PTY LTD LEVEL 2 37 EPPING ROADMACQUARIE PARK, NSW 2113 AUSTRALIA

Inventors
CodeFirstnameSurname
3839444 CLARKE, ADAM
3839445 POLLARD, MATTHEW
3839446 DOYLE, ANTHONY, GERARD
3839447 BEHRENS, COLLETTE
3839448 YAMAGISHI, TETSUO
3839449 WILSON, DAVID, S. JR.
3839450 POGUE, SARAH, L.
3839451 TAURA, TETSUYA

Representatives
CodeFirstnameSurnameAddressTownZip
3614AIKATERINISIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"PATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History

Title Instruments

Payments history 13 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015